series-c-plus
Stage
1
Investors
About
Adverum Biotechnologies develops gene therapies to treat severe ocular and rare diseases using its proprietary gene delivery technology.
Explore Adverum Biotechnologies's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.